Markus Lankers PhD MIBIC GmbH & Co KG

Markus is one of the co-founders of MIBIC GmbH a company that develops rapid bacteria identification systems. Within MIBIC Markus is responsible for research and development of new spectroscopic methods for bacteria analysis. He has 25 years of experience in the field of particle identification. In 2002 he founded rap.ID Particle Systems GmbH and served as Managing Director until the sale of the company in 2018. Before this position, he worked as a scientist in different development departments at Schering AG, Berlin, Germany. Markus holds a diploma. in Chemistry and a Ph.D. in Physical Chemistry from the University of Würzburg. He is an active member of the Parenteral Drug Association (PDA). Since 2003 he helped to establish the Visual Inspection of Parenterals Interest Group in Europe as European interest group leader. He served as program co-chair for the PDA Visual Inspection Forum of Partenterals 2001-2018 in Europe and the USA.